Zobrazeno 1 - 10
of 542
pro vyhledávání: '"Xiubao REN"'
Autor:
Jingjing Pu, Ting Liu, Amit Sharma, Liping Jiang, Feng Wei, Xiubao Ren, Ingo G. H. Schmidt-Wolf, Jian Hou
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-29 (2024)
Abstract The basic idea of modulating the immune system to better recognize and fight tumor cells has led to the successful introduction of adoptive cellular immunotherapy (ACT). ACT-based treatment regimens, in which the patient's own immune cells a
Externí odkaz:
https://doaj.org/article/285baec50f1c434e8a0e2bf8bf15f536
Autor:
Yanjuan Xiong, Lu Wang, Weihong Zhang, Yuan Meng, Yang Wang, Meng Shen, Li Zhou, Runmei Li, Yingge Lv, Shengguang Wang, Xiubao Ren, Liang Liu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background The safety and efficacy of combination of gefitinib with chemotherapy and bevacizumab in treatment patients with epidermal growth factor receptor (EGFR) mutations are currently unknown. This study was designed to evaluate the safe
Externí odkaz:
https://doaj.org/article/b0881b39702747e19b426a096714747e
Publikováno v:
Cell Death and Disease, Vol 15, Iss 10, Pp 1-13 (2024)
Abstract Immune checkpoint inhibitors (ICIs) immunotherapy facilitates new approaches to achieve precision cancer treatment. A growing number of patients with non-small cell lung cancer (NSCLC) have benefited from treatment with neoadjuvant ICIs comb
Externí odkaz:
https://doaj.org/article/0bcdda18406d4c0fb29a68494b434b2f
Autor:
Jian Zhang, Ping Lu, Hui Zhao, Jianhua Chen, Wei Shi, Xiubao Ren, Yi Hu, Liping Wang, Hongmei Zhang, Chengchu Zhu, Jianping Xiong, Jianying Zhou, Jun Zhao, Yongqian Shu, Caicun Zhou, Xiaorong Dong, Yunpeng Liu, Yunchao Huang, Jian Zhao, Yiping Zhang, Sheng Hu, Xiaoyan Lin, Yueyin Pan, Jiuwei Cui, Lizhu Lin, Kangsheng Gu, Yun Fan, Qun Chen, Gongyan Chen, Zhehai Wang, Fengying Wu, Guangyu An, Shuliang Guo, Xiaodong Jiang, Yongsheng Wang, Jifeng Feng, Jianhua Shi, QiMing Wang, Jianan Huang, Lejie Cao, Jianhua Chang, Zhiyong He, Jian Fang, Faguang Jin, Hongjun Gao, Cuimin Ding, Xiangdong Zhou, Anwen Liu, Jianjin Huang, Beili Gao, Yinglan Chen, Chengping Hu, Zhigao Wang, Xinjing Ma
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background CameL phase 3 study demonstrated the superiority of camrelizumab plus chemotherapy over chemotherapy alone for progression-free survival in patients with previously untreated advanced non-squamous non-small-cell lung cancer (NSCLC) without
Externí odkaz:
https://doaj.org/article/fa2babd2caa04c86aa782e11c5e58721
Autor:
Michael Lee, Jing Chen, Li Yao, Yu Chen, Yu Jiang, Feng Li, Xiubao Ren, Jun Guo, Bixia Tang, Chuanliang Cui, Gang Huang, Shuai Zhao, Zhihong Chi, Meng Qi, Xiaolu Tao, Quanli Gao, Xiaoshi Zhang, Meiyu Fang, Fei Zheng, Rongqing Li, Meijuan Gao, Ruixuan Luo, Rong Duan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 10 (2024)
Background HBM4003 is a novel anti-CTLA-4 heavy chain-only antibody, designed to enhance Treg ablation and antibody-dependent cell-mediated cytotoxicity while ensuring a manageable safety profile. This phase I trial investigated the safety, pharmacok
Externí odkaz:
https://doaj.org/article/999bac7efb2d43c483ff80494758b040
Autor:
Yuan Meng, Yingge Lv, Meng Shen, Wenwen Yu, Yumeng Liu, Ting Liu, Gen Liu, Shiya Ma, Zhenzhen Hui, Xiubao Ren, Liang Liu
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Objective Immunotherapy, specifically immune checkpoint inhibitors (ICIs), has revolutionized cancer treatment. However, it can also cause immune‐related adverse events (irAEs). This study aimed to develop a clinically practical animal mod
Externí odkaz:
https://doaj.org/article/1d5e22df1b17444bad25975fca0ae157
Autor:
Junlei Jia, Xiaohui Wang, Zheng Song, Shen Meng, Yue Fei, Jingwei Yu, Xia Liu, Xue Han, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Wenchen Gong, Bin Meng, Xiubao Ren, Xianhuo Wang, Huilai Zhang
Publikováno v:
Cancer Biology & Medicine, Vol 21, Iss 3, Pp 223-229 (2024)
Externí odkaz:
https://doaj.org/article/0e200376c12545268d4cfda6060a3a87
Autor:
Huijing Feng, Siyuan Zhang, Qiuru Zhou, Fei Han, Gang Du, Lin Wang, Xuena Yang, Xiying Zhang, Wenwen Yu, Feng Wei, Xishan Hao, Xiubao Ren, Hua Zhao
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/f8768b0408e9465f80dcb861774fc246
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/ce13cf7547ba46bb8b9d909d14d88988
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 12, Pp 903-914 (2023)
Externí odkaz:
https://doaj.org/article/478130efab12498a9ef8d67b18d4f280